Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.24844006 |
2 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.00345583 |
3 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.95844835 |
4 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.91547291 |
5 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.91547291 |
6 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.90157176 |
7 | membrane budding (GO:0006900) | 2.87208470 |
8 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.85537397 |
9 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.83801708 |
10 | protein neddylation (GO:0045116) | 2.76214293 |
11 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.74402144 |
12 | respiratory electron transport chain (GO:0022904) | 2.72223303 |
13 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.69528173 |
14 | electron transport chain (GO:0022900) | 2.69448814 |
15 | membrane raft organization (GO:0031579) | 2.61278854 |
16 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.57634715 |
17 | auditory receptor cell differentiation (GO:0042491) | 2.56691763 |
18 | transferrin transport (GO:0033572) | 2.54837274 |
19 | angiogenesis involved in wound healing (GO:0060055) | 2.54521980 |
20 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.54508403 |
21 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.54508403 |
22 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.53268380 |
23 | neurofilament cytoskeleton organization (GO:0060052) | 2.51997309 |
24 | norepinephrine metabolic process (GO:0042415) | 2.51697776 |
25 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.51312126 |
26 | phagosome maturation (GO:0090382) | 2.50727939 |
27 | trivalent inorganic cation transport (GO:0072512) | 2.48171630 |
28 | ferric iron transport (GO:0015682) | 2.48171630 |
29 | macroautophagy (GO:0016236) | 2.46563010 |
30 | regulation of dopamine secretion (GO:0014059) | 2.45471288 |
31 | neuronal action potential propagation (GO:0019227) | 2.44718568 |
32 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.44170863 |
33 | ATP synthesis coupled proton transport (GO:0015986) | 2.44170863 |
34 | negative regulation of cation channel activity (GO:2001258) | 2.44110907 |
35 | negative regulation of protein localization to cell surface (GO:2000009) | 2.43864080 |
36 | fatty acid elongation (GO:0030497) | 2.43640480 |
37 | cellular copper ion homeostasis (GO:0006878) | 2.43184322 |
38 | desmosome organization (GO:0002934) | 2.41545222 |
39 | positive regulation of fatty acid oxidation (GO:0046321) | 2.38827616 |
40 | positive regulation of catecholamine secretion (GO:0033605) | 2.37249192 |
41 | positive regulation of vesicle fusion (GO:0031340) | 2.36579916 |
42 | hypotonic response (GO:0006971) | 2.34733937 |
43 | protein targeting to plasma membrane (GO:0072661) | 2.34566762 |
44 | inositol phosphate-mediated signaling (GO:0048016) | 2.33834371 |
45 | smooth muscle tissue development (GO:0048745) | 2.32564106 |
46 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.31515976 |
47 | induction of positive chemotaxis (GO:0050930) | 2.31225246 |
48 | regulation of female receptivity (GO:0045924) | 2.30164611 |
49 | regulation of sequestering of triglyceride (GO:0010889) | 2.28049204 |
50 | negative regulation of amino acid transport (GO:0051956) | 2.25866142 |
51 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.24980930 |
52 | serotonin metabolic process (GO:0042428) | 2.24757775 |
53 | synaptic vesicle exocytosis (GO:0016079) | 2.24340364 |
54 | protein maturation by protein folding (GO:0022417) | 2.23907366 |
55 | protein localization to endosome (GO:0036010) | 2.21826531 |
56 | regulation of monocyte chemotaxis (GO:0090025) | 2.21643819 |
57 | ER overload response (GO:0006983) | 2.20776590 |
58 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.19633122 |
59 | hydrogen ion transmembrane transport (GO:1902600) | 2.19171488 |
60 | response to gravity (GO:0009629) | 2.18467553 |
61 | behavioral response to nicotine (GO:0035095) | 2.17489378 |
62 | nitric oxide mediated signal transduction (GO:0007263) | 2.17023324 |
63 | iron ion transport (GO:0006826) | 2.15366620 |
64 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.15178977 |
65 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.14662375 |
66 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.14581983 |
67 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.14581983 |
68 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.14064110 |
69 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.14059149 |
70 | positive regulation of glomerulus development (GO:0090193) | 2.13942256 |
71 | keratan sulfate catabolic process (GO:0042340) | 2.13706464 |
72 | regulation of glutamate secretion (GO:0014048) | 2.13694900 |
73 | membrane repolarization during action potential (GO:0086011) | 2.13427762 |
74 | negative regulation of complement activation (GO:0045916) | 2.13334419 |
75 | copper ion homeostasis (GO:0055070) | 2.13334339 |
76 | hemidesmosome assembly (GO:0031581) | 2.13160073 |
77 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.13004417 |
78 | phospholipid scrambling (GO:0017121) | 2.12499469 |
79 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.12382679 |
80 | type B pancreatic cell proliferation (GO:0044342) | 2.12213404 |
81 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.10971423 |
82 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.10631790 |
83 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.10617308 |
84 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.08771427 |
85 | primary amino compound metabolic process (GO:1901160) | 2.08678158 |
86 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.07924162 |
87 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.07456983 |
88 | cardiac conduction (GO:0061337) | 2.06478174 |
89 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.06432392 |
90 | cell adhesion mediated by integrin (GO:0033627) | 2.06320360 |
91 | detection of temperature stimulus (GO:0016048) | 2.05774275 |
92 | barbed-end actin filament capping (GO:0051016) | 2.04280304 |
93 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.04156188 |
94 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.03521767 |
95 | adhesion of symbiont to host cell (GO:0044650) | 2.03338003 |
96 | virion attachment to host cell (GO:0019062) | 2.03338003 |
97 | positive regulation of actin filament depolymerization (GO:0030836) | 2.02321575 |
98 | myelin maintenance (GO:0043217) | 2.02286452 |
99 | proton transport (GO:0015992) | 2.02185907 |
100 | glutamate secretion (GO:0014047) | 2.01319501 |
101 | activation of protein kinase B activity (GO:0032148) | 2.00738934 |
102 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.00484337 |
103 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.00231711 |
104 | hydrogen transport (GO:0006818) | 1.99665535 |
105 | sequestering of actin monomers (GO:0042989) | 1.99299869 |
106 | detection of bacterium (GO:0016045) | 1.99139531 |
107 | sequestering of extracellular ligand from receptor (GO:0035581) | 1.99031493 |
108 | interleukin-1-mediated signaling pathway (GO:0070498) | 1.98949134 |
109 | positive regulation of receptor recycling (GO:0001921) | 1.98887224 |
110 | regulation of heart rate by cardiac conduction (GO:0086091) | 1.98591788 |
111 | regulation of glomerulus development (GO:0090192) | 1.97989695 |
112 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 1.97926435 |
113 | negative regulation of glycogen metabolic process (GO:0070874) | 1.96362030 |
114 | transcytosis (GO:0045056) | 1.95445684 |
115 | regulation of receptor binding (GO:1900120) | 1.94261836 |
116 | long term synaptic depression (GO:0060292) | 1.94036544 |
117 | aldehyde catabolic process (GO:0046185) | 1.93516740 |
118 | detection of other organism (GO:0098543) | 1.92928806 |
119 | regulation of cell communication by electrical coupling (GO:0010649) | 1.91918963 |
120 | regulation of voltage-gated calcium channel activity (GO:1901385) | 1.91605970 |
121 | pattern specification involved in kidney development (GO:0061004) | 1.91391834 |
122 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 1.91157130 |
123 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.91029101 |
124 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 1.90971765 |
125 | cellular iron ion homeostasis (GO:0006879) | 1.89987833 |
126 | glutathione derivative metabolic process (GO:1901685) | 1.89501642 |
127 | glutathione derivative biosynthetic process (GO:1901687) | 1.89501642 |
128 | cellular transition metal ion homeostasis (GO:0046916) | 1.89370165 |
129 | mating behavior (GO:0007617) | 1.88311599 |
130 | glutathione biosynthetic process (GO:0006750) | 1.88165388 |
131 | tonic smooth muscle contraction (GO:0014820) | 1.88154589 |
132 | synaptic vesicle maturation (GO:0016188) | 1.88017599 |
133 | regulation of fatty acid oxidation (GO:0046320) | 1.87881179 |
134 | amyloid precursor protein catabolic process (GO:0042987) | 1.87589759 |
135 | response to water (GO:0009415) | 1.87292505 |
136 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 1.86876850 |
137 | amyloid precursor protein metabolic process (GO:0042982) | 1.86862964 |
138 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 1.86528324 |
139 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 1.86436666 |
140 | regulation of lipoprotein metabolic process (GO:0050746) | 1.86047174 |
141 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 1.85808491 |
142 | NADH metabolic process (GO:0006734) | 1.84526066 |
143 | regulation of transforming growth factor beta1 production (GO:0032908) | 1.84519095 |
144 | actin filament depolymerization (GO:0030042) | 1.84456772 |
145 | female mating behavior (GO:0060180) | 1.84249524 |
146 | succinate metabolic process (GO:0006105) | 1.83830620 |
147 | positive regulation of glycolytic process (GO:0045821) | 1.83700295 |
148 | membrane assembly (GO:0071709) | 1.83190201 |
149 | plasma membrane repair (GO:0001778) | 1.83018259 |
150 | negative regulation of protein activation cascade (GO:2000258) | 1.82937961 |
151 | sphingoid metabolic process (GO:0046519) | 1.82412402 |
152 | Golgi to plasma membrane protein transport (GO:0043001) | 1.81896450 |
153 | regulation of phospholipase A2 activity (GO:0032429) | 1.81028627 |
154 | extracellular fibril organization (GO:0043206) | 1.80761107 |
155 | negative regulation of platelet activation (GO:0010544) | 1.80050897 |
156 | regulation of autophagic vacuole assembly (GO:2000785) | 1.78605827 |
157 | relaxation of smooth muscle (GO:0044557) | 1.77979034 |
158 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 1.77369329 |
159 | detection of calcium ion (GO:0005513) | 1.77196845 |
160 | establishment of protein localization to plasma membrane (GO:0090002) | 1.76977851 |
161 | regulation of cholesterol storage (GO:0010885) | 1.76735133 |
162 | astrocyte differentiation (GO:0048708) | 1.76233705 |
163 | endocardial cushion development (GO:0003197) | 1.75986108 |
164 | negative regulation of lipid storage (GO:0010888) | 1.75740712 |
165 | peptide hormone processing (GO:0016486) | 1.75440027 |
166 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 1.74876851 |
167 | regulation of metalloenzyme activity (GO:0048552) | 1.74244768 |
168 | negative regulation of glycogen biosynthetic process (GO:0045719) | 1.74243887 |
169 | growth hormone receptor signaling pathway (GO:0060396) | 1.74042549 |
170 | regulation of memory T cell differentiation (GO:0043380) | 1.72884114 |
171 | negative regulation of response to food (GO:0032096) | 1.72479550 |
172 | negative regulation of appetite (GO:0032099) | 1.72479550 |
173 | positive regulation of phosphatase activity (GO:0010922) | 1.72362581 |
174 | regulation of protein localization to cell surface (GO:2000008) | 1.70643217 |
175 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 1.69599195 |
176 | sarcomere organization (GO:0045214) | 1.68087284 |
177 | glandular epithelial cell differentiation (GO:0002067) | 1.67605011 |
178 | magnesium ion transport (GO:0015693) | 1.67475323 |
179 | fibril organization (GO:0097435) | 1.66824807 |
180 | muscle cell migration (GO:0014812) | 1.66761822 |
181 | calcium ion-dependent exocytosis (GO:0017156) | 1.66170056 |
182 | regulation of skeletal muscle contraction (GO:0014819) | 1.66036664 |
183 | cellular potassium ion homeostasis (GO:0030007) | 1.65958466 |
184 | regulation of receptor recycling (GO:0001919) | 1.65774051 |
185 | peptide catabolic process (GO:0043171) | 1.65465930 |
186 | termination of signal transduction (GO:0023021) | 1.65372872 |
187 | dendritic spine morphogenesis (GO:0060997) | 1.65253978 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.63444246 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.58743947 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.41889016 |
4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.38809598 |
5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.24219189 |
6 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.18679999 |
7 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.18679999 |
8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.10656936 |
9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.03357033 |
10 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.99606260 |
11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.95960459 |
12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.95712845 |
13 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.86968110 |
14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.85939146 |
15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.84784708 |
16 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.84724415 |
17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.80433228 |
18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69335884 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.68394881 |
20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.67034527 |
21 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.64960232 |
22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61166036 |
23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.60437834 |
24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59174419 |
25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.58891503 |
26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.54531020 |
27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.53577236 |
28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52129794 |
29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47759544 |
30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45799708 |
31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.44427429 |
32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37793200 |
33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.36479292 |
34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.35897958 |
35 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.35897958 |
36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.35471224 |
37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34897048 |
38 | CJUN_26792858_Chip-Seq_BT549_Human | 1.33774838 |
39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32459812 |
40 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32126571 |
41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32094243 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30962912 |
43 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.29892593 |
44 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29668693 |
45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.28880269 |
46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.28003179 |
47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27711642 |
48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27343634 |
49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22769370 |
50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19017468 |
51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16983560 |
52 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16415763 |
53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15290349 |
54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15174744 |
55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14690816 |
56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.12156923 |
57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11900530 |
58 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.11823944 |
59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08634007 |
60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08320411 |
61 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.07923721 |
62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07632157 |
63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07243072 |
64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06959370 |
65 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03991112 |
66 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03467795 |
67 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02849678 |
68 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02506717 |
69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02038491 |
70 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00872784 |
71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00872738 |
72 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99419768 |
73 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.97588562 |
74 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97334189 |
75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96730497 |
76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96298519 |
77 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.96175633 |
78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96103751 |
79 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95592942 |
80 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95026344 |
81 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94902741 |
82 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93858427 |
83 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93252109 |
84 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93190728 |
85 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92684529 |
86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92667186 |
87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92654785 |
88 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91716105 |
89 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91177165 |
90 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91177165 |
91 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.89660537 |
92 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89235944 |
93 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89235944 |
94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88938301 |
95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88892925 |
96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88778978 |
97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88609692 |
98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87700998 |
99 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87696472 |
100 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.87647391 |
101 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86733743 |
102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86603676 |
103 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85667746 |
104 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.85661433 |
105 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.85298709 |
106 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85197911 |
107 | TP53_16413492_ChIP-PET_HCT116_Human | 0.84587652 |
108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84496456 |
109 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.84396180 |
110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84132228 |
111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84132228 |
112 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83718864 |
113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83027949 |
114 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.82822332 |
115 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.82590502 |
116 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82337031 |
117 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82002341 |
118 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.81775629 |
119 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81449204 |
120 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81258734 |
121 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.81068173 |
122 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81021301 |
123 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80838166 |
124 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.80743692 |
125 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.80462998 |
126 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79982385 |
127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78881104 |
128 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.78656880 |
129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78119935 |
130 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78028308 |
131 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77386167 |
132 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.77209252 |
133 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.76986642 |
134 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76479651 |
135 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.75811141 |
136 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.74518526 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002822_catalepsy | 3.64449349 |
2 | MP0004147_increased_porphyrin_level | 3.28134596 |
3 | MP0010234_abnormal_vibrissa_follicle | 2.84353061 |
4 | MP0002735_abnormal_chemical_nociception | 2.69246720 |
5 | MP0005275_abnormal_skin_tensile | 2.41071330 |
6 | MP0002736_abnormal_nociception_after | 2.32142344 |
7 | MP0001968_abnormal_touch/_nociception | 2.30463233 |
8 | MP0009379_abnormal_foot_pigmentation | 2.29241110 |
9 | MP0005058_abnormal_lysosome_morphology | 2.21804140 |
10 | MP0008438_abnormal_cutaneous_collagen | 2.12344622 |
11 | MP0003195_calcinosis | 2.09225612 |
12 | MP0004270_analgesia | 2.08974340 |
13 | MP0010386_abnormal_urinary_bladder | 2.06565221 |
14 | MP0000013_abnormal_adipose_tissue | 2.02527180 |
15 | MP0005167_abnormal_blood-brain_barrier | 1.94308945 |
16 | MP0002796_impaired_skin_barrier | 1.91805499 |
17 | MP0003646_muscle_fatigue | 1.91649330 |
18 | MP0002733_abnormal_thermal_nociception | 1.87026779 |
19 | MP0002295_abnormal_pulmonary_circulatio | 1.75742404 |
20 | MP0005083_abnormal_biliary_tract | 1.74616227 |
21 | MP0002734_abnormal_mechanical_nocicepti | 1.72889654 |
22 | MP0004043_abnormal_pH_regulation | 1.72281602 |
23 | MP0001970_abnormal_pain_threshold | 1.68743401 |
24 | MP0005503_abnormal_tendon_morphology | 1.67573038 |
25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.67458007 |
26 | MP0008775_abnormal_heart_ventricle | 1.63818221 |
27 | MP0004885_abnormal_endolymph | 1.57013243 |
28 | MP0002837_dystrophic_cardiac_calcinosis | 1.56115172 |
29 | MP0005408_hypopigmentation | 1.56066179 |
30 | MP0003191_abnormal_cellular_cholesterol | 1.55561286 |
31 | MP0003329_amyloid_beta_deposits | 1.50910954 |
32 | MP0002909_abnormal_adrenal_gland | 1.48153009 |
33 | MP0005171_absent_coat_pigmentation | 1.46319350 |
34 | MP0003806_abnormal_nucleotide_metabolis | 1.46275417 |
35 | MP0005464_abnormal_platelet_physiology | 1.45377210 |
36 | MP0005085_abnormal_gallbladder_physiolo | 1.43947127 |
37 | MP0003011_delayed_dark_adaptation | 1.43711632 |
38 | MP0001905_abnormal_dopamine_level | 1.43213136 |
39 | MP0000372_irregular_coat_pigmentation | 1.42274119 |
40 | MP0005646_abnormal_pituitary_gland | 1.42255648 |
41 | MP0001986_abnormal_taste_sensitivity | 1.41737384 |
42 | MP0003186_abnormal_redox_activity | 1.41507363 |
43 | MP0001533_abnormal_skeleton_physiology | 1.41289937 |
44 | MP0003950_abnormal_plasma_membrane | 1.40559000 |
45 | MP0010678_abnormal_skin_adnexa | 1.39667711 |
46 | MP0008004_abnormal_stomach_pH | 1.38743656 |
47 | MP0003656_abnormal_erythrocyte_physiolo | 1.36021284 |
48 | MP0005409_darkened_coat_color | 1.33345408 |
49 | MP0003638_abnormal_response/metabolism_ | 1.31829386 |
50 | MP0003828_pulmonary_edema | 1.31790964 |
51 | MP0003690_abnormal_glial_cell | 1.31509928 |
52 | MP0005084_abnormal_gallbladder_morpholo | 1.30687037 |
53 | MP0004859_abnormal_synaptic_plasticity | 1.30245408 |
54 | MP0001542_abnormal_bone_strength | 1.28052641 |
55 | MP0005670_abnormal_white_adipose | 1.27760586 |
56 | MP0000920_abnormal_myelination | 1.26851786 |
57 | MP0005360_urolithiasis | 1.26366156 |
58 | MP0001756_abnormal_urination | 1.26095014 |
59 | MP0000383_abnormal_hair_follicle | 1.23898842 |
60 | MP0004272_abnormal_basement_membrane | 1.23551322 |
61 | MP0003880_abnormal_central_pattern | 1.23463349 |
62 | MP0001765_abnormal_ion_homeostasis | 1.23429902 |
63 | MP0004510_myositis | 1.23427298 |
64 | MP0003183_abnormal_peptide_metabolism | 1.20530825 |
65 | MP0002064_seizures | 1.19999939 |
66 | MP0002896_abnormal_bone_mineralization | 1.19339955 |
67 | MP0003633_abnormal_nervous_system | 1.16683255 |
68 | MP0002272_abnormal_nervous_system | 1.15874921 |
69 | MP0002139_abnormal_hepatobiliary_system | 1.15378434 |
70 | MP0004858_abnormal_nervous_system | 1.14352305 |
71 | MP0009745_abnormal_behavioral_response | 1.12794079 |
72 | MP0000604_amyloidosis | 1.11710431 |
73 | MP0000427_abnormal_hair_cycle | 1.11575427 |
74 | MP0001440_abnormal_grooming_behavior | 1.10538810 |
75 | MP0003279_aneurysm | 1.10188703 |
76 | MP0005165_increased_susceptibility_to | 1.08919084 |
77 | MP0000749_muscle_degeneration | 1.07762928 |
78 | MP0003635_abnormal_synaptic_transmissio | 1.07325686 |
79 | MP0009780_abnormal_chondrocyte_physiolo | 1.06421387 |
80 | MP0005636_abnormal_mineral_homeostasis | 1.05807160 |
81 | MP0009046_muscle_twitch | 1.05640452 |
82 | MP0006276_abnormal_autonomic_nervous | 1.04550034 |
83 | MP0005257_abnormal_intraocular_pressure | 1.02983685 |
84 | MP0003724_increased_susceptibility_to | 1.01147885 |
85 | MP0004215_abnormal_myocardial_fiber | 1.00410311 |
86 | MP0000230_abnormal_systemic_arterial | 0.99710946 |
87 | MP0004484_altered_response_of | 0.98511501 |
88 | MP0009643_abnormal_urine_homeostasis | 0.97820651 |
89 | MP0005620_abnormal_muscle_contractility | 0.97184798 |
90 | MP0001666_abnormal_nutrient_absorption | 0.95835216 |
91 | MP0001879_abnormal_lymphatic_vessel | 0.94773905 |
92 | MP0001529_abnormal_vocalization | 0.94636473 |
93 | MP0002877_abnormal_melanocyte_morpholog | 0.93065477 |
94 | MP0005023_abnormal_wound_healing | 0.92727766 |
95 | MP0000751_myopathy | 0.91891056 |
96 | MP0002971_abnormal_brown_adipose | 0.91088518 |
97 | MP0004019_abnormal_vitamin_homeostasis | 0.90798990 |
98 | MP0002090_abnormal_vision | 0.90792346 |
99 | MP0000538_abnormal_urinary_bladder | 0.90707566 |
100 | MP0003566_abnormal_cell_adhesion | 0.90543462 |
101 | MP0005390_skeleton_phenotype | 0.88807542 |
102 | MP0005164_abnormal_response_to | 0.88388152 |
103 | MP0010771_integument_phenotype | 0.88273209 |
104 | MP0004036_abnormal_muscle_relaxation | 0.88171101 |
105 | MP0002060_abnormal_skin_morphology | 0.88055243 |
106 | MP0001958_emphysema | 0.87972105 |
107 | MP0001501_abnormal_sleep_pattern | 0.87603863 |
108 | MP0005332_abnormal_amino_acid | 0.87381635 |
109 | MP0003075_altered_response_to | 0.86996860 |
110 | MP0004145_abnormal_muscle_electrophysio | 0.86888730 |
111 | MP0010368_abnormal_lymphatic_system | 0.86748741 |
112 | MP0004084_abnormal_cardiac_muscle | 0.86068363 |
113 | MP0009053_abnormal_anal_canal | 0.85900243 |
114 | MP0004130_abnormal_muscle_cell | 0.84769460 |
115 | MP0004085_abnormal_heartbeat | 0.84488496 |
116 | MP0005385_cardiovascular_system_phenoty | 0.83174058 |
117 | MP0001544_abnormal_cardiovascular_syste | 0.83174058 |
118 | MP0000767_abnormal_smooth_muscle | 0.82697826 |
119 | MP0006036_abnormal_mitochondrial_physio | 0.82612532 |
120 | MP0000678_abnormal_parathyroid_gland | 0.82501322 |
121 | MP0003045_fibrosis | 0.82269908 |
122 | MP0009384_cardiac_valve_regurgitation | 0.82045200 |
123 | MP0000747_muscle_weakness | 0.81757069 |
124 | MP0005535_abnormal_body_temperature | 0.81450074 |
125 | MP0000467_abnormal_esophagus_morphology | 0.80681148 |
126 | MP0001664_abnormal_digestion | 0.79944436 |
127 | MP0005595_abnormal_vascular_smooth | 0.79772157 |
128 | MP0006054_spinal_hemorrhage | 0.79234667 |
129 | MP0002118_abnormal_lipid_homeostasis | 0.79022378 |
130 | MP0000343_altered_response_to | 0.78986229 |
131 | MP0002876_abnormal_thyroid_physiology | 0.78452047 |
132 | MP0003631_nervous_system_phenotype | 0.78316366 |
133 | MP0003705_abnormal_hypodermis_morpholog | 0.77942296 |
134 | MP0008874_decreased_physiological_sensi | 0.77742003 |
135 | MP0005501_abnormal_skin_physiology | 0.77409516 |
136 | MP0003879_abnormal_hair_cell | 0.77081724 |
137 | MP0005448_abnormal_energy_balance | 0.76069652 |
138 | MP0002972_abnormal_cardiac_muscle | 0.75731957 |
139 | MP0002998_abnormal_bone_remodeling | 0.73986567 |
140 | MP0003300_gastrointestinal_ulcer | 0.73267141 |
141 | MP0010329_abnormal_lipoprotein_level | 0.73262281 |
142 | MP0001348_abnormal_lacrimal_gland | 0.73145397 |
143 | MP0004947_skin_inflammation | 0.72885270 |
144 | MP0003436_decreased_susceptibility_to | 0.72761657 |
145 | MP0002067_abnormal_sensory_capabilities | 0.72655718 |
146 | MP0002063_abnormal_learning/memory/cond | 0.71651524 |
147 | MP0004883_abnormal_blood_vessel | 0.71572578 |
148 | MP0006138_congestive_heart_failure | 0.68453880 |
149 | MP0000465_gastrointestinal_hemorrhage | 0.68429068 |
150 | MP0000249_abnormal_blood_vessel | 0.67985396 |
151 | MP0005379_endocrine/exocrine_gland_phen | 0.65698625 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 4.04957128 |
2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.55132685 |
3 | Axonal loss (HP:0003447) | 3.42749622 |
4 | Ventricular fibrillation (HP:0001663) | 3.23733225 |
5 | Bundle branch block (HP:0011710) | 3.22722456 |
6 | Hypothermia (HP:0002045) | 3.16125405 |
7 | Acute necrotizing encephalopathy (HP:0006965) | 3.05380357 |
8 | Atonic seizures (HP:0010819) | 2.94988952 |
9 | Cardiovascular calcification (HP:0011915) | 2.91763253 |
10 | Vascular calcification (HP:0004934) | 2.91692308 |
11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.87861034 |
12 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.80476670 |
13 | Acute encephalopathy (HP:0006846) | 2.79354574 |
14 | Mitral stenosis (HP:0001718) | 2.73483908 |
15 | Vacuolated lymphocytes (HP:0001922) | 2.69869712 |
16 | Right ventricular cardiomyopathy (HP:0011663) | 2.67277960 |
17 | Progressive macrocephaly (HP:0004481) | 2.66147959 |
18 | Ileus (HP:0002595) | 2.66132064 |
19 | Ulnar claw (HP:0001178) | 2.64692497 |
20 | Type 1 muscle fiber predominance (HP:0003803) | 2.63704941 |
21 | Hematochezia (HP:0002573) | 2.59690659 |
22 | Abnormality of magnesium homeostasis (HP:0004921) | 2.55803191 |
23 | Congenital sensorineural hearing impairment (HP:0008527) | 2.52646357 |
24 | Increased cerebral lipofuscin (HP:0011813) | 2.52105412 |
25 | Protrusio acetabuli (HP:0003179) | 2.52058131 |
26 | Striae distensae (HP:0001065) | 2.51146749 |
27 | Pheochromocytoma (HP:0002666) | 2.49853927 |
28 | Mitochondrial inheritance (HP:0001427) | 2.49266792 |
29 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.47306543 |
30 | Asymmetric septal hypertrophy (HP:0001670) | 2.46618096 |
31 | Cerebral hemorrhage (HP:0001342) | 2.46343894 |
32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46041576 |
33 | Bone cyst (HP:0012062) | 2.45011170 |
34 | Oligomenorrhea (HP:0000876) | 2.44228052 |
35 | Metaphyseal dysplasia (HP:0100255) | 2.42710127 |
36 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.40752373 |
37 | Myotonia (HP:0002486) | 2.40024823 |
38 | Sensorimotor neuropathy (HP:0007141) | 2.39048894 |
39 | Ventricular arrhythmia (HP:0004308) | 2.37915655 |
40 | Syncope (HP:0001279) | 2.37266760 |
41 | Nemaline bodies (HP:0003798) | 2.36908921 |
42 | Hypomagnesemia (HP:0002917) | 2.36349921 |
43 | Neuroendocrine neoplasm (HP:0100634) | 2.33813727 |
44 | Decreased circulating renin level (HP:0003351) | 2.32175666 |
45 | Systemic lupus erythematosus (HP:0002725) | 2.30684210 |
46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.29002806 |
47 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.28384750 |
48 | Focal motor seizures (HP:0011153) | 2.25760470 |
49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.24627349 |
50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24319252 |
51 | Mucopolysacchariduria (HP:0008155) | 2.24319252 |
52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22544152 |
53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22544152 |
54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22544152 |
55 | Vascular tortuosity (HP:0004948) | 2.21852487 |
56 | Hyperlipoproteinemia (HP:0010980) | 2.21599053 |
57 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.17662420 |
58 | Menorrhagia (HP:0000132) | 2.17452750 |
59 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.17155760 |
60 | Abnormal hemoglobin (HP:0011902) | 2.16153134 |
61 | Fatigable weakness (HP:0003473) | 2.14533357 |
62 | Abnormality of the neuromuscular junction (HP:0003398) | 2.14533357 |
63 | Muscle stiffness (HP:0003552) | 2.14187516 |
64 | Autoamputation (HP:0001218) | 2.13348371 |
65 | Aortic aneurysm (HP:0004942) | 2.13307239 |
66 | Neurofibrillary tangles (HP:0002185) | 2.12437183 |
67 | Prolonged bleeding time (HP:0003010) | 2.11277866 |
68 | Aortic dissection (HP:0002647) | 2.09291146 |
69 | Hyporeflexia of lower limbs (HP:0002600) | 2.08952427 |
70 | Xanthomatosis (HP:0000991) | 2.08777806 |
71 | Hyperthyroidism (HP:0000836) | 2.08181161 |
72 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.07712354 |
73 | Follicular hyperkeratosis (HP:0007502) | 2.07484117 |
74 | Muscle fiber inclusion bodies (HP:0100299) | 2.05795178 |
75 | Hepatocellular necrosis (HP:0001404) | 2.05259222 |
76 | Parakeratosis (HP:0001036) | 2.05107473 |
77 | Thick nail (HP:0001805) | 2.04215833 |
78 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.03757797 |
79 | Neck muscle weakness (HP:0000467) | 2.03087933 |
80 | Conjunctival hamartoma (HP:0100780) | 2.02636659 |
81 | Ulnar deviation of the wrist (HP:0003049) | 2.02233113 |
82 | Hyperphosphatemia (HP:0002905) | 2.00428503 |
83 | Hepatic necrosis (HP:0002605) | 1.99925386 |
84 | Arterial tortuosity (HP:0005116) | 1.99120608 |
85 | Adrenal hypoplasia (HP:0000835) | 1.98732752 |
86 | Increased CSF protein (HP:0002922) | 1.98289251 |
87 | Peritonitis (HP:0002586) | 1.96894979 |
88 | Hyperactive renin-angiotensin system (HP:0000841) | 1.96305047 |
89 | Increased CSF lactate (HP:0002490) | 1.96090451 |
90 | Palpitations (HP:0001962) | 1.94372303 |
91 | Bradycardia (HP:0001662) | 1.94343032 |
92 | Vertebral compression fractures (HP:0002953) | 1.94231619 |
93 | Abnormal atrioventricular conduction (HP:0005150) | 1.94020700 |
94 | Cerebral edema (HP:0002181) | 1.93371885 |
95 | Abnormal gallbladder physiology (HP:0012438) | 1.92431084 |
96 | Cholecystitis (HP:0001082) | 1.92431084 |
97 | Acanthosis nigricans (HP:0000956) | 1.91361023 |
98 | Round ear (HP:0100830) | 1.91337767 |
99 | Skin nodule (HP:0200036) | 1.91044119 |
100 | Abnormal EKG (HP:0003115) | 1.90744247 |
101 | Decreased central vision (HP:0007663) | 1.89791747 |
102 | Action tremor (HP:0002345) | 1.89594938 |
103 | Beaking of vertebral bodies (HP:0004568) | 1.89038428 |
104 | Spinal rigidity (HP:0003306) | 1.89036723 |
105 | Termporal pattern (HP:0011008) | 1.88918192 |
106 | Insidious onset (HP:0003587) | 1.88918192 |
107 | Respiratory failure (HP:0002878) | 1.87996777 |
108 | Absence seizures (HP:0002121) | 1.87365875 |
109 | Dysostosis multiplex (HP:0000943) | 1.84779638 |
110 | Increased circulating renin level (HP:0000848) | 1.84578815 |
111 | Cervical subluxation (HP:0003308) | 1.83599704 |
112 | Agitation (HP:0000713) | 1.83157862 |
113 | Hypokalemic alkalosis (HP:0001949) | 1.81688209 |
114 | Glucose intolerance (HP:0000833) | 1.81553611 |
115 | Increased intramyocellular lipid droplets (HP:0012240) | 1.81252013 |
116 | Distal lower limb muscle weakness (HP:0009053) | 1.80000458 |
117 | Alopecia of scalp (HP:0002293) | 1.79150835 |
118 | Atrophic scars (HP:0001075) | 1.79042849 |
119 | Hyperglycemia (HP:0003074) | 1.78570605 |
120 | Atrial fibrillation (HP:0005110) | 1.78270288 |
121 | Amyloidosis (HP:0011034) | 1.78011844 |
122 | Abnormality of renin-angiotensin system (HP:0000847) | 1.77558373 |
123 | Purpura (HP:0000979) | 1.77281747 |
124 | Premature rupture of membranes (HP:0001788) | 1.76897453 |
125 | Abnormality of the costochondral junction (HP:0000919) | 1.76705003 |
126 | Absent/shortened dynein arms (HP:0200106) | 1.76325104 |
127 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.76325104 |
128 | Sensory axonal neuropathy (HP:0003390) | 1.76320742 |
129 | Increased muscle lipid content (HP:0009058) | 1.76010542 |
130 | Absent phalangeal crease (HP:0006109) | 1.75114504 |
131 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.75065671 |
132 | Testicular neoplasm (HP:0010788) | 1.74255816 |
133 | Foot dorsiflexor weakness (HP:0009027) | 1.72575728 |
134 | Growth hormone excess (HP:0000845) | 1.72201619 |
135 | Sudden death (HP:0001699) | 1.71788204 |
136 | Heart block (HP:0012722) | 1.71666120 |
137 | Cerebral inclusion bodies (HP:0100314) | 1.70615914 |
138 | Joint stiffness (HP:0001387) | 1.68403417 |
139 | Abnormality of proline metabolism (HP:0010907) | 1.68346911 |
140 | Hydroxyprolinuria (HP:0003080) | 1.68346911 |
141 | Hypokinesia (HP:0002375) | 1.67729408 |
142 | Metabolic alkalosis (HP:0200114) | 1.67458521 |
143 | Abnormality of Sharpey fibers (HP:0100685) | 1.66726478 |
144 | Dialeptic seizures (HP:0011146) | 1.66527819 |
145 | Postural tremor (HP:0002174) | 1.66003619 |
146 | Hyperparathyroidism (HP:0000843) | 1.65295208 |
147 | Chondrocalcinosis (HP:0000934) | 1.65026576 |
148 | Osteoarthritis (HP:0002758) | 1.64731189 |
149 | Torticollis (HP:0000473) | 1.64189675 |
150 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.63931976 |
151 | Keratoconus (HP:0000563) | 1.63804166 |
152 | Increased corneal curvature (HP:0100692) | 1.63804166 |
153 | X-linked dominant inheritance (HP:0001423) | 1.63710168 |
154 | Loss of speech (HP:0002371) | 1.63250103 |
155 | Episodic fever (HP:0001954) | 1.63030257 |
156 | Primary atrial arrhythmia (HP:0001692) | 1.62873463 |
157 | Abnormality of the vocal cords (HP:0008777) | 1.62289053 |
158 | Abnormality of complement system (HP:0005339) | 1.62285863 |
159 | Spinal canal stenosis (HP:0003416) | 1.61564190 |
160 | Short femoral neck (HP:0100864) | 1.61295545 |
161 | Congenital stationary night blindness (HP:0007642) | 1.61141545 |
162 | Abnormality of the nasal septum (HP:0000419) | 1.60671145 |
163 | Supraventricular tachycardia (HP:0004755) | 1.60267966 |
164 | Anxiety (HP:0000739) | 1.59952532 |
165 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.58931751 |
166 | Abnormality of glycolipid metabolism (HP:0010969) | 1.58931751 |
167 | Stridor (HP:0010307) | 1.58429142 |
168 | Glomerulonephritis (HP:0000099) | 1.58259364 |
169 | Hypoglycemic coma (HP:0001325) | 1.57738394 |
170 | Abnormal eating behavior (HP:0100738) | 1.57238807 |
171 | Glycosuria (HP:0003076) | 1.57206953 |
172 | Abnormality of urine glucose concentration (HP:0011016) | 1.57206953 |
173 | Renal Fanconi syndrome (HP:0001994) | 1.57152317 |
174 | Upper limb amyotrophy (HP:0009129) | 1.56891813 |
175 | Distal upper limb amyotrophy (HP:0007149) | 1.56891813 |
176 | Onion bulb formation (HP:0003383) | 1.56688654 |
177 | Craniofacial dystonia (HP:0012179) | 1.56594677 |
178 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.56551976 |
179 | Resting tremor (HP:0002322) | 1.56417417 |
180 | Focal seizures (HP:0007359) | 1.56243682 |
181 | Progressive inability to walk (HP:0002505) | 1.56171745 |
182 | Dysautonomia (HP:0002459) | 1.55837563 |
183 | Increased connective tissue (HP:0009025) | 1.55365235 |
184 | Fragile skin (HP:0001030) | 1.55069251 |
185 | Plantar hyperkeratosis (HP:0007556) | 1.54731178 |
186 | Exercise intolerance (HP:0003546) | 1.53926595 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ARAF | 3.23068885 |
2 | MAP3K12 | 2.96980100 |
3 | KSR2 | 2.65406792 |
4 | MAP3K2 | 2.63581848 |
5 | MST1R | 2.32818779 |
6 | FRK | 2.32388385 |
7 | NTRK1 | 2.27360282 |
8 | GRK5 | 2.25399849 |
9 | RIPK4 | 2.20478616 |
10 | LIMK1 | 2.14625563 |
11 | STK39 | 2.14219962 |
12 | MYLK | 2.06389578 |
13 | MST4 | 1.91642489 |
14 | MAP3K9 | 1.85747731 |
15 | EPHB2 | 1.82447050 |
16 | WNK4 | 1.81839150 |
17 | CAMKK2 | 1.72782050 |
18 | BCR | 1.70550791 |
19 | MAP2K1 | 1.70450933 |
20 | PIM2 | 1.70294373 |
21 | PHKG2 | 1.69573077 |
22 | PHKG1 | 1.69573077 |
23 | FER | 1.67711688 |
24 | MINK1 | 1.63579656 |
25 | OXSR1 | 1.62674748 |
26 | PINK1 | 1.59384474 |
27 | MET | 1.57820538 |
28 | TESK1 | 1.52147275 |
29 | TIE1 | 1.50363424 |
30 | MAPKAPK5 | 1.48709031 |
31 | MAP2K2 | 1.45693468 |
32 | LMTK2 | 1.37463095 |
33 | SIK3 | 1.30094765 |
34 | TAOK3 | 1.29211609 |
35 | PLK2 | 1.27999154 |
36 | MAPKAPK3 | 1.27303206 |
37 | RIPK1 | 1.23678171 |
38 | EPHA4 | 1.23512253 |
39 | DAPK2 | 1.21007226 |
40 | MAP3K6 | 1.20888375 |
41 | BMPR2 | 1.14470042 |
42 | PTK2B | 1.13407612 |
43 | NTRK3 | 1.13175661 |
44 | PIK3CA | 1.08862653 |
45 | ZAP70 | 1.08372558 |
46 | INSRR | 1.07831050 |
47 | EPHB1 | 1.07778301 |
48 | TRPM7 | 1.06413326 |
49 | SIK1 | 1.06045218 |
50 | MAP2K3 | 1.04313363 |
51 | MAP2K6 | 1.03437124 |
52 | NME2 | 1.03361455 |
53 | MAP3K1 | 1.03009504 |
54 | STK38 | 1.01675963 |
55 | ACVR1B | 1.00424933 |
56 | DMPK | 1.00393658 |
57 | MAP3K3 | 0.99075715 |
58 | GRK7 | 0.98840429 |
59 | LRRK2 | 0.98821839 |
60 | PDK2 | 0.97617898 |
61 | PRKG2 | 0.97564814 |
62 | ADRBK2 | 0.96894982 |
63 | DAPK3 | 0.96625844 |
64 | MUSK | 0.95057553 |
65 | SGK223 | 0.94874468 |
66 | SGK494 | 0.94874468 |
67 | EPHA3 | 0.94654024 |
68 | OBSCN | 0.93882645 |
69 | PRKCE | 0.89196087 |
70 | GRK1 | 0.87213031 |
71 | RET | 0.86391957 |
72 | WNK1 | 0.85325199 |
73 | BRAF | 0.84044351 |
74 | PRKD2 | 0.79988064 |
75 | PBK | 0.79966884 |
76 | RAF1 | 0.78961048 |
77 | ROCK1 | 0.78949397 |
78 | CDC42BPA | 0.77908792 |
79 | CSK | 0.77162251 |
80 | PAK3 | 0.76939990 |
81 | MOS | 0.76367558 |
82 | CASK | 0.74059704 |
83 | CAMKK1 | 0.71471844 |
84 | IRAK3 | 0.71223799 |
85 | MAP2K4 | 0.70942965 |
86 | CAMK2D | 0.69691792 |
87 | BCKDK | 0.67449944 |
88 | RPS6KA2 | 0.66008847 |
89 | TESK2 | 0.65903931 |
90 | STK24 | 0.64498511 |
91 | ADRBK1 | 0.64255958 |
92 | PRKAA2 | 0.64086532 |
93 | SGK3 | 0.62980308 |
94 | PDPK1 | 0.62858458 |
95 | ILK | 0.62673195 |
96 | CAMK2G | 0.62271596 |
97 | CAMK1 | 0.61522650 |
98 | CAMK2B | 0.61230626 |
99 | JAK1 | 0.60927985 |
100 | ABL2 | 0.60872200 |
101 | ERN1 | 0.60609952 |
102 | NME1 | 0.60486070 |
103 | STK3 | 0.58646641 |
104 | PDGFRB | 0.58617318 |
105 | NEK9 | 0.58266803 |
106 | CAMK2A | 0.56683606 |
107 | CDK5 | 0.55356741 |
108 | MAP3K13 | 0.54842954 |
109 | HIPK2 | 0.54261489 |
110 | IKBKB | 0.51529944 |
111 | PIK3CG | 0.50553400 |
112 | CHUK | 0.50370788 |
113 | SGK2 | 0.49029214 |
114 | ERBB2 | 0.48366116 |
115 | PRKD3 | 0.48317108 |
116 | PRKD1 | 0.47830165 |
117 | AKT3 | 0.47168632 |
118 | TGFBR2 | 0.47012816 |
119 | EPHA2 | 0.46930969 |
120 | CDK14 | 0.46820146 |
121 | PAK6 | 0.42564008 |
122 | MATK | 0.42079072 |
123 | LATS2 | 0.41585046 |
124 | PTK2 | 0.40091225 |
125 | ROCK2 | 0.39868615 |
126 | KSR1 | 0.39688789 |
127 | TTN | 0.38795631 |
128 | PDK1 | 0.38284238 |
129 | PRKCH | 0.36757497 |
130 | CDK18 | 0.34442942 |
131 | FYN | 0.33990686 |
132 | PRKCG | 0.33914290 |
133 | DDR2 | 0.32601612 |
134 | PRKCA | 0.32500873 |
135 | PRKACA | 0.31785708 |
136 | SRC | 0.30757755 |
137 | IGF1R | 0.30169368 |
138 | PRKCD | 0.30092462 |
139 | SCYL2 | 0.28682060 |
140 | ERBB3 | 0.28619173 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.03084692 |
2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.74216762 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.42830778 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.29727662 |
5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.18392633 |
6 | Alzheimers disease_Homo sapiens_hsa05010 | 2.08097701 |
7 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.07410413 |
8 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.75835587 |
9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.68698405 |
10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.62969367 |
11 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57658615 |
12 | Protein export_Homo sapiens_hsa03060 | 1.57345240 |
13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51213275 |
14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48608235 |
15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.47005954 |
16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.40837933 |
17 | Phagosome_Homo sapiens_hsa04145 | 1.38225180 |
18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.36074611 |
19 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.34882216 |
20 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.34472986 |
21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.34375920 |
22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32928739 |
23 | Lysosome_Homo sapiens_hsa04142 | 1.28270493 |
24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21075905 |
25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20113376 |
26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17944614 |
27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.16475255 |
28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15918960 |
29 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.15515288 |
30 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.14611245 |
31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.13605998 |
32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.12939276 |
33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12519898 |
34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10985265 |
35 | Salivary secretion_Homo sapiens_hsa04970 | 1.10326956 |
36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.09982098 |
37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.08392314 |
38 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.07804579 |
39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.07346721 |
40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04635842 |
41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01765691 |
42 | Focal adhesion_Homo sapiens_hsa04510 | 0.99626559 |
43 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97396415 |
44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96507627 |
45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95948547 |
46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.95813651 |
47 | Mineral absorption_Homo sapiens_hsa04978 | 0.94693138 |
48 | Olfactory transduction_Homo sapiens_hsa04740 | 0.94107023 |
49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93970579 |
50 | Long-term depression_Homo sapiens_hsa04730 | 0.91141071 |
51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.90894182 |
52 | Renin secretion_Homo sapiens_hsa04924 | 0.90558909 |
53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89813309 |
54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.89547437 |
55 | Insulin resistance_Homo sapiens_hsa04931 | 0.89264079 |
56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.88579343 |
57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86159088 |
58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.85105821 |
59 | Phototransduction_Homo sapiens_hsa04744 | 0.84623630 |
60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84174157 |
61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82978136 |
62 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82689059 |
63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82473681 |
64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82224222 |
65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81919594 |
66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81855561 |
67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80817389 |
68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.79892472 |
69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79847273 |
70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79798272 |
71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.79080880 |
72 | Long-term potentiation_Homo sapiens_hsa04720 | 0.78857708 |
73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76537883 |
74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76113071 |
75 | Pertussis_Homo sapiens_hsa05133 | 0.75781306 |
76 | Circadian entrainment_Homo sapiens_hsa04713 | 0.75499272 |
77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75121638 |
78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74972181 |
79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74360112 |
80 | Peroxisome_Homo sapiens_hsa04146 | 0.73709312 |
81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72243985 |
82 | GABAergic synapse_Homo sapiens_hsa04727 | 0.72227546 |
83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71129912 |
84 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.70977929 |
85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67725107 |
86 | Insulin secretion_Homo sapiens_hsa04911 | 0.67088980 |
87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66700235 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66580507 |
89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66259086 |
90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65477630 |
91 | Salmonella infection_Homo sapiens_hsa05132 | 0.65434698 |
92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64390050 |
93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64245175 |
94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63772239 |
95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62720372 |
96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61896705 |
97 | Bile secretion_Homo sapiens_hsa04976 | 0.61779736 |
98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59973727 |
99 | Gap junction_Homo sapiens_hsa04540 | 0.59475277 |
100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59369601 |
101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58893936 |
102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58845319 |
103 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58444516 |
104 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57106666 |
105 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.56674063 |
106 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55895239 |
107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55693581 |
108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55051652 |
109 | Proteasome_Homo sapiens_hsa03050 | 0.54606626 |
110 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54343571 |
111 | Amoebiasis_Homo sapiens_hsa05146 | 0.53928645 |
112 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53664151 |
113 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53263909 |
114 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52734420 |
115 | Taste transduction_Homo sapiens_hsa04742 | 0.52127778 |
116 | Malaria_Homo sapiens_hsa05144 | 0.51916070 |
117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50843881 |
118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50779190 |
119 | Morphine addiction_Homo sapiens_hsa05032 | 0.49646712 |
120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49299751 |
121 | Axon guidance_Homo sapiens_hsa04360 | 0.48962313 |
122 | Tight junction_Homo sapiens_hsa04530 | 0.48941567 |
123 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48600586 |
124 | Shigellosis_Homo sapiens_hsa05131 | 0.48550435 |
125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48245943 |
126 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47151237 |
127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47008780 |
128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46610745 |
129 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46531789 |
130 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46038010 |
131 | * Endocytosis_Homo sapiens_hsa04144 | 0.45072522 |
132 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44947231 |
133 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.43495478 |
134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42855067 |
135 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40145970 |
136 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39907289 |
137 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38449581 |
138 | Platelet activation_Homo sapiens_hsa04611 | 0.38206525 |